| Year |
Citation |
Score |
| 2024 |
Gómez Tejeda Zañudo J, Barroso-Sousa R, Jain E, Jin Q, Li T, Buendia-Buendia JE, Pereslete A, Abravanel DL, Ferreira AR, Wrabel E, Helvie K, Hughes ME, Partridge AH, Overmoyer B, Lin NU, et al. Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial. Nature Communications. 15: 2446. PMID 38503755 DOI: 10.1038/s41467-024-45835-6 |
0.342 |
|
| 2015 |
Abravanel DL, Belka GK, Pan TC, Pant DK, Collins MA, Sterner CJ, Chodosh LA. Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy. The Journal of Clinical Investigation. 125: 2484-96. PMID 25961456 DOI: 10.1172/Jci74883 |
0.639 |
|
| 2015 |
Abravanel DL, Collins MA, Belka GK, Pan T, Pant DK, Sterner CJ, Chodosh LA. Abstract 2894: Notch signaling promotes survival and recurrence of dormant mammary tumor cells following HER2/neu targeted therapy Cancer Research. 75: 2894-2894. DOI: 10.1158/1538-7445.Am2015-2894 |
0.639 |
|
| 2012 |
Abravanel DL, Sterner CJ, Pan T, Belka GK, Chodosh LA. Abstract A32: Notch signaling regulates recurrence in a model of HER2 targeted therapy Clinical Cancer Research. 18: A32-A32. DOI: 10.1158/1078-0432.Mechres-A32 |
0.634 |
|
| 2009 |
Plentz R, Park JS, Rhim AD, Abravanel D, Hezel AF, Sharma SV, Gurumurthy S, Deshpande V, Kenific C, Settleman J, Majumder PK, Stanger BZ, Bardeesy N. Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma. Gastroenterology. 136: 1741-9.e6. PMID 19208345 DOI: 10.1053/J.Gastro.2009.01.008 |
0.447 |
|
| Show low-probability matches. |